46
Participants
Start Date
January 24, 2019
Primary Completion Date
December 31, 2020
Study Completion Date
December 31, 2020
Lamotrigine 300 MG
300 mg of oral Lamotrigine. One of the key studies in this area was reported at the Society of Neuroscience meeting in 1997 and later published in the Archives of General Psychiatry. This study reported that, in healthy subjects 300 mg oral lamotrigine significantly decreased ketamine-induced perceptual abnormalities as assessed by the Clinician-Administered Dissociative States Scale (P\<.001).31 Furthermore lamotrigine increased the immediate mood-elevating effects of ketamine (P\<.05).
Placebo
300 mg of oral Placebo
Ketamine
1mg/kg bolus at induction followed by 5 microgram/kg/min infusion till the end of the surgery
Cleveland Clinic, Cleveland
The Cleveland Clinic
OTHER